Nukkleus Inc. (NASDAQ:NUKK) Sees Large Growth in Short Interest

Nukkleus Inc. (NASDAQ:NUKK) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totaling 2,268,303 shares, a growth of 25.2% from the December 15th total of 1,811,274 shares. Approximately 14.8% of the shares of the company are sold short. Based on an average daily volume of 855,324 shares, the short-interest ratio is currently 2.7 days. Based on an average daily volume of 855,324 shares, the short-interest ratio is currently 2.7 days. Approximately 14.8% of the shares of the company are sold short.

Nukkleus Stock Down 5.7%

NUKK traded down $0.20 during trading hours on Tuesday, reaching $3.29. 547,428 shares of the company’s stock traded hands, compared to its average volume of 1,719,079. The firm has a 50-day moving average price of $4.79 and a 200 day moving average price of $6.07. The firm has a market capitalization of $54.81 million, a PE ratio of 0.20 and a beta of -6.67. Nukkleus has a 52-week low of $3.20 and a 52-week high of $32.90.

Insiders Place Their Bets

In related news, major shareholder Sc Capital Ii Sponsor Llc bought 255,000 shares of the stock in a transaction that occurred on Friday, November 28th. The shares were bought at an average cost of $10.00 per share, for a total transaction of $2,550,000.00. Following the completion of the transaction, the insider owned 255,000 shares of the company’s stock, valued at approximately $2,550,000. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Anastasiia Kotaieva sold 75,000 shares of Nukkleus stock in a transaction on Monday, December 29th. The shares were sold at an average price of $4.09, for a total value of $306,750.00. Following the transaction, the insider owned 75,000 shares in the company, valued at $306,750. This trade represents a 50.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 394,952 shares of company stock worth $1,745,457. 7.90% of the stock is owned by insiders.

Institutional Trading of Nukkleus

Large investors have recently made changes to their positions in the stock. BNP Paribas Financial Markets purchased a new position in Nukkleus in the 2nd quarter worth about $56,000. Ausdal Financial Partners Inc. purchased a new stake in Nukkleus in the 3rd quarter valued at about $105,000. Finally, UBS Group AG grew its stake in Nukkleus by 23.3% in the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after acquiring an additional 15,223 shares in the last quarter. 12.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Wall Street Zen raised shares of Nukkleus from a “sell” rating to a “hold” rating in a research note on Sunday, November 23rd. Weiss Ratings reissued a “sell (d+)” rating on shares of Nukkleus in a research note on Wednesday, December 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Nukkleus presently has a consensus rating of “Sell”.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.